The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective analysis of safety and efficacy of ipilimumab in elderly patients with advanced melanoma.
 
Andrew Cota Shaw
No Relationships to Disclose
 
VanAnh Trinh
No Relationships to Disclose
 
Roland L. Bassett
No Relationships to Disclose
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene; Idera; Nektar; Pfizer
Travel, Accommodations, Expenses - Nektar
 
Rodabe Navroze Amaria
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - Dava Oncology; PCME, Rockpointe; PlatformQ Health
Consulting or Advisory Role - Amgen; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb (Mexico); Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)